Adrian Kilcoyne
Chief Tech/Sci/R&D Officer bij CELULARITY INC.
Vermogen: 586 932 $ op 31-03-2024
Profiel
Adrian Kilcoyne is currently the Chief Medical Officer & Executive Vice President at Celularity, Inc. Prior to this, he worked as the VP, Head-US Medical Affairs & Health Economics at AstraZeneca PLC.
He also served as the Chief Medical Officer at Humanigen, Inc. from 2021 to 2022.
Dr. Kilcoyne has a graduate degree from Warwick Business School and the University of London.
He also holds a doctorate degree from Trinity College Dublin.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CELULARITY INC. CLASS A
0.52% | 17-02-2024 | 112 224 ( 0.52% ) | 586 932 $ | 31-03-2024 |
Actieve functies van Adrian Kilcoyne
| Bedrijven | Functie | Begin |
|---|---|---|
| CELULARITY INC. | Chief Tech/Sci/R&D Officer | 03-10-2022 |
Eerdere bekende functies van Adrian Kilcoyne
| Bedrijven | Functie | Einde |
|---|---|---|
| HUMANIGEN, INC. | Chief Tech/Sci/R&D Officer | 28-09-2022 |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Opleiding van Adrian Kilcoyne
| Warwick Business School | Graduate Degree |
| University of London | Graduate Degree |
| Trinity College Dublin | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| HUMANIGEN, INC. | Health Technology |
| CELULARITY INC. | Commercial Services |
